Thursday, June 3, 2010

Lawsuit claims Wyeth targeted African Americans illegally for off label use of drug

Pharmalot is reporting that two former hospital sales reps have filed a whistleblower suit alleging Wyeth, which is now owned by Pfizer, illegally promoted its Rapamune kidney transplant drug for use with other organs and targeted African-Americans, even though this is a high-risk patient group. Go here for the full story.

No comments: